|
| 36709532 | Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patients. | Mol Genet Metab | 2023 |
| 36965478 | Bi-allelic SNAPC4 variants dysregulate global alternative splicing and lead to neuroregression and progressive spastic paraparesis. | Am J Hum Genet | 2023 |
| 35171800 | [Neurodevelopmental disorders: from the laboratory to the classroom]. | Medicina (B Aires) | 2022 |
| 32815557 | Autism in neurofibromatosis type 1: misuse of covariance to dismiss autistic trait burden. | Dev Med Child Neurol | 2021 |
| 35096477 | Clinician- and Patient-reported Endpoints in CNS Orphan Drug Clinical Trials: ISCTM Position Paper on Best Practices for Endpoint Selection, Validation, Training, and Standardization. | Innov Clin Neurosci | 2021 |
| 34472416 | Computerized Working Memory Training for Children With Neurofibromatosis Type 1 (NF1): A Pilot Study. | J Child Neurol | 2021 |
| 31838937 | Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1. | J Atten Disord | 2021 |
| 32617712 | An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains. | Childs Nerv Syst | 2020 |
| 32026187 | Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders. | Behav Genet | 2020 |
| 30696812 | ADGRL3 (LPHN3) variants predict substance use disorder. | Transl Psychiatry | 2019 |
| 31797581 | Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1. | Ann Clin Transl Neurol | 2019 |
| 31603840 | [Sleep, memory and learning]. | Medicina (B Aires) | 2019 |
| 31626395 | Circle of Willis anomalies in Turner syndrome: Absent A1 segment of the anterior cerebral artery. | Birth Defects Res | 2019 |
| 28891274 | Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer. | Genes Chromosomes Cancer | 2018 |
| 30104415 | Germline and Somatic <i>NF1</i> Alterations Are Linked to Increased HER2 Expression in Breast Cancer. | Cancer Prev Res (Phila) | 2018 |
| 30199367 | [Attention deficit hyperactivity disorder beyond adolescence. Time to think different?] | Medicina (B Aires) | 2018 |
| 28605662 | Computerized cognitive training for children with neurofibromatosis type 1: A pilot resting-state fMRI study. | Psychiatry Res Neuroimaging | 2017 |
| 28295312 | Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. | J Child Psychol Psychiatry | 2017 |
| 27510231 | Retrospective assessment of childhood ADHD symptoms for diagnosis in adults: validity of a short 8-item version of the Wender-Utah Rating Scale. | Atten Defic Hyperact Disord | 2016 |
| 26598068 | Linkage and association analysis of ADHD endophenotypes in extended and multigenerational pedigrees from a genetic isolate. | Mol Psychiatry | 2016 |
| 27760236 | Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT). | JAMA Psychiatry | 2016 |
| 27692237 | An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility. | Biol Psychiatry | 2016 |
| 27956565 | Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. | Neurology | 2016 |
| 27652281 | ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study. | Mol Genet Genomic Med | 2016 |
| 27144034 | Neural Plasticity in Obesity and Psychiatric Disorders. | Neural Plast | 2016 |
| 25920923 | Searching for molecular-targeted interventions for NF1 cognitive deficits in the classroom. | Dev Med Child Neurol | 2015 |
| 24443315 | CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. | Am J Med Genet A | 2014 |
| 24435762 | Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. | JAMA Ophthalmol | 2014 |
| 23163951 | Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. | Dev Med Child Neurol | 2013 |
| 24107290 | Challenges of cognitive research in neurofibromatosis type 1. | Lancet Neurol | 2013 |
| 23453281 | Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas. | Am J Ophthalmol | 2013 |
| 21606926 | A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD. | Mol Psychiatry | 2012 |
| 23012086 | Analysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit/hyperactivity disorder suggests a generalized differential ontogenic pattern from controls. | Atten Defic Hyperact Disord | 2012 |
| 22433254 | Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1. | Neurosci Lett | 2012 |
| 22490768 | Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformations. | Pediatr Neurol | 2012 |
| 22083253 | Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting. | Acta Neuropathol | 2012 |
| 21615350 | Isolated seizures in rats do not cause neuronal injury. | Acta Neurol Scand | 2012 |
| 21271647 | Back to the future: proceedings from the 2010 NF Conference. | Am J Med Genet A | 2011 |
| 22832519 | A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome. | Transl Psychiatry | 2011 |
| 21779842 | Potential cognitive endophenotypes in multigenerational families: segregating ADHD from a genetic isolate. | Atten Defic Hyperact Disord | 2011 |
| 21907886 | Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study. | Pediatr Neurol | 2011 |
| 21365598 | [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder]. | Rev Neurol | 2011 |
| 21094952 | Mental, motor, and language development of toddlers with neurofibromatosis type 1. | J Pediatr | 2011 |
| 19951270 | Arterial spin labeling demonstrates that focal amygdalar glutamatergic agonist infusion leads to rapid diffuse cerebral activation. | Acta Neurol Scand | 2010 |
| 20445195 | Cerebellar atrophy in human and murine succinic semialdehyde dehydrogenase deficiency. | J Child Neurol | 2010 |
| 20157310 | A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. | Mol Psychiatry | 2010 |
| 18520958 | Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions. | J Am Acad Child Adolesc Psychiatry | 2008 |
| 17467976 | Tuning major gene variants conditioning human behavior: the anachronism of ADHD. | Curr Opin Genet Dev | 2007 |
| 17347943 | [Genetic and molecular aspects in attention deficit hyperactivity disorder: the search for the genes involved in clinical diagnosis]. | Rev Neurol | 2007 |
| 17347941 | [The neurobiology of learning difficulties: neurofibromatosis type 1 as a model for researching and treating learning disorders]. | Rev Neurol | 2007 |